Enhanced paclitaxel oral delivery by astragalus polysaccharide-based nanoplatform for triple-negative breast cancer treatment
{{output}}
Oral delivery of paclitaxel (PTX) is hindered by poor aqueous solubility, low bioavailability, and gastrointestinal toxicity, limiting its clinical breast cancer treatment. Here, we developed a novel oral nanoplatform (APS-PTX NPs) using Astragalus polysacchar... ...
